More on APGE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)

Upcoming Events

- Earnings (9/1/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Apogee Therapeutics (NQ:APGE)
Delayed: 73.05 +2.13 (3.00%)
Prev. Close $70.92  
Open$70.26 
52 Wk High$0.02 
52 Wk Low$0.02 
Day High$73.17 
Day Low$69.10 
P/E N/A  
EPS$0.00 
Volume607,065 

Friends, Peers and Foes (?): REGN, INCY, NBIX, AMGN, LLY (more...)

Mar 6, 2026 08:00 PM Form 4 Apogee Therapeutics, For: Mar 04 Filed by: Dambkowski Carl
Mar 6, 2026 12:58 PM Form SCHEDULE 13G Apogee Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
Mar 5, 2026 05:02 AM Citi Opens Catalyst Watch on Apogee Therapeutics Inc (APGE)
Mar 4, 2026 08:02 PM Form 4 Apogee Therapeutics, For: Mar 02 Filed by: Henderson Jane
Mar 2, 2026 03:49 PM Apogee Therapeutics Inc (APGE) PT Lowered to $82 at RBC Capital
Mar 2, 2026 09:07 AM Apogee Therapeutics Inc (APGE) PT Raised to $95 at Wedbush
Mar 2, 2026 07:33 AM Form S-8 Apogee Therapeutics,
Mar 2, 2026 07:21 AM Form 10-K Apogee Therapeutics, For: Dec 31
Mar 2, 2026 07:15 AM Form 8-K Apogee Therapeutics, For: Mar 02
Mar 2, 2026 07:01 AM Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results
View All Articles

Entities mentioned with APGE

View All Entities